Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

62.17USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$62.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,821
52-wk High
$76.98
52-wk Low
$36.49

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.01 December 12 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 2 2 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.43 1.43

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.26 1.14 0.00 0.77
Quarter Ending Mar-19 1 0.00 0.00 0.00 0.40
Year Ending Dec-18 8 0.24 1.23 0.00 2.06
Year Ending Dec-19 7 1.54 10.00 0.00 1.81
Earnings (per share)
Quarter Ending Dec-18 6 -1.01 -0.87 -1.15 -0.76
Quarter Ending Mar-19 2 -1.02 -0.96 -1.08 --
Year Ending Dec-18 8 -3.44 -3.28 -3.63 -3.12
Year Ending Dec-19 7 -3.84 -1.38 -4.83 -3.66

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.08 0.02 0.06 76.08
Quarter Ending Jun-18 0.09 0.02 0.07 78.97
Quarter Ending Mar-18 0.41 0.03 0.38 93.16
Quarter Ending Dec-17 0.36 0.28 0.08 21.28
Quarter Ending Sep-17 0.62 0.43 0.18 29.48

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.26 0.26 0.26 0.26 0.77
Quarter Ending Mar-19 0.00 0.00 0.00 0.00 0.40
Year Ending Dec-18 0.24 0.24 1.06 1.20 2.06
Year Ending Dec-19 1.54 1.54 1.54 1.78 1.81

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 2 4
Year Ending Dec-19 0 0 1 0
Earnings